| Prediction of venous thromboembolism in cancer patients C Ay, D Dunkler, C Marosi, AL Chiriac, R Vormittag, R Simanek, ... Blood, The Journal of the American Society of Hematology 116 (24), 5377-5382, 2010 | 1008 | 2010 |
| American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer GH Lyman, M Carrier, C Ay, M Di Nisio, LK Hicks, AA Khorana, AD Leavitt, ... Blood advances 5 (4), 927-974, 2021 | 976 | 2021 |
| Venous thromboembolism in cancer patients: a population-based cohort study FI Mulder, E Horvàth-Puhó, N van Es, HWM Van Laarhoven, L Pedersen, ... Blood, The Journal of the American Society of Hematology 137 (14), 1959-1969, 2021 | 711 | 2021 |
| D-dimer and prothrombin fragment 1+ 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study C Ay, R Vormittag, D Dunkler, R Simanek, AL Chiriac, J Drach, ... Journal of Clinical Oncology 27 (25), 4124-4129, 2009 | 592 | 2009 |
| Cancer-associated venous thromboembolism: burden, mechanisms, and management C Ay, I Pabinger, AT Cohen Thrombosis and haemostasis 117 (02), 219-230, 2017 | 576 | 2017 |
| Risk of venous thromboembolism in patients with COVID‐19: a systematic review and meta‐analysis S Nopp, F Moik, B Jilma, I Pabinger, C Ay Research and practice in thrombosis and haemostasis 4 (7), 1178-1191, 2020 | 571 | 2020 |
| High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS) C Ay, R Simanek, R Vormittag, D Dunkler, G Alguel, S Koder, G Kornek, ... Blood, The Journal of the American Society of Hematology 112 (7), 2703-2708, 2008 | 555 | 2008 |
| 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer D Farge, C Frere, JM Connors, C Ay, AA Khorana, A Munoz, B Brenner, ... The Lancet Oncology 20 (10), e566-e581, 2019 | 528 | 2019 |
| High D-dimer levels are associated with poor prognosis in cancer patients C Ay, D Dunkler, R Pirker, J Thaler, P Quehenberger, O Wagner, ... haematologica 97 (8), 1158, 2012 | 485 | 2012 |
| 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19 D Farge, C Frere, JM Connors, AA Khorana, A Kakkar, C Ay, A Muñoz, ... The Lancet Oncology 23 (7), e334-e347, 2022 | 418 | 2022 |
| Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline A Falanga, C Ay, M Di Nisio, G Gerotziafas, L Jara-Palomares, F Langer, ... Annals of Oncology 34 (5), 452-467, 2023 | 378 | 2023 |
| A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts I Pabinger, N van Es, G Heinze, F Posch, J Riedl, EM Reitter, M Di Nisio, ... The Lancet Haematology 5 (7), e289-e298, 2018 | 358 | 2018 |
| Microparticle‐associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients J Thaler, C Ay, N Mackman, RM Bertina, A Kaider, C Marosi, NS Key, ... Journal of Thrombosis and Haemostasis 10 (7), 1363-1370, 2012 | 348 | 2012 |
| Outpatient pulmonary rehabilitation in patients with long COVID improves exercise capacity, functional status, dyspnea, fatigue, and quality of life S Nopp, F Moik, FA Klok, D Gattinger, M Petrovic, K Vonbank, ... Respiration 101 (6), 593-601, 2022 | 346 | 2022 |
| High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS) R Simanek, R Vormittag, C Ay, G Alguel, D Dunkler, I Schwarzinger, ... Journal of Thrombosis and Haemostasis 8 (1), 114-120, 2010 | 325 | 2010 |
| Diagnosis and management of vaccine-related thrombosis following AstraZeneca COVID-19 vaccination: guidance statement from the GTH J Oldenburg, R Klamroth, F Langer, M Albisetti, C Von Auer, C Ay, ... Hämostaseologie 41 (03), 184-189, 2021 | 323 | 2021 |
| Biomarkers for prediction of venous thromboembolism in cancer I Pabinger, J Thaler, C Ay Blood, The Journal of the American Society of Hematology 122 (12), 2011-2018, 2013 | 323 | 2013 |
| Citrullinated histone H3, a biomarker of neutrophil extracellular trap formation, predicts the risk of venous thromboembolism in cancer patients LM Mauracher, F Posch, K Martinod, E Grilz, T Däullary, L Hell, C Brostjan, ... Journal of Thrombosis and Haemostasis 16 (3), 508-518, 2018 | 295 | 2018 |
| Biomarkers and venous thromboembolism I Pabinger, C Ay Arteriosclerosis, thrombosis, and vascular biology 29 (3), 332-336, 2009 | 293 | 2009 |
| Treatment of venous thromboembolism in patients with cancer: a network meta-analysis comparing efficacy and safety of anticoagulants F Posch, O Königsbrügge, C Zielinski, I Pabinger, C Ay Thrombosis research 136 (3), 582-589, 2015 | 284 | 2015 |
Pabinger Ingrid or Pabinger-Faching I...Medical University Vienna, Division of Haematology and HaemostaseologyVerified email at meduniwien.ac.at
